SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (1824)4/30/1998 3:49:00 AM
From: Michael Ohlendorf  Read Replies (1) | Respond to of 9523
 
Saw a Viagra report on Swiss TV last night. They said that in some Swiss regions (Kantone) it is already being sold (Tessin, Zuerich) in others the local drug commissions are testing it for approval. There is supposed to exist a considerable grey market already. The official approval in Switzerland is expected for May.



To: Anthony Wong who wrote (1824)4/30/1998 12:31:00 PM
From: alexander orlov  Read Replies (4) | Respond to of 9523
 
TAP's candidate drug (apomorphine) is very weak as compared to viagra.it will present no threat to viagra.. cs first boston wants your shares for their clients.. i am not giving them my shares...


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News